Associations between bullous pemphigoid and hematological diseases: Literature review on mechanistic connections and possible treatments

Front Immunol. 2023 Mar 8:14:1155181. doi: 10.3389/fimmu.2023.1155181. eCollection 2023.

Abstract

Bullous pemphigoid is an autoimmune blistering disorder that primarily occurs in elderly patients. Reports indicate that BP coexists with various hematological diseases, including acquired hemophilia A, hypereosinophilic syndrome, aplastic anemia, autoimmune thrombocytopenia, and hematological malignancies. Early identification of these comorbidities contributes to a better control and reduced mortality. This article details the atypical clinical manifestations of BP when associated with hematological diseases, specific diagnostic strategies, underlying mechanistic connections, and possible treatments. Cross-reactivity between autoantibodies and exposed abnormal epitopes, shared cytokines and immune cells, together with genetic susceptibility are the most common connections between BP and hematological diseases. Patients were most often successfully treated with oral steroids combined with medications specifically targeting the hematological disorders. However, the individual comorbidities require specific considerations.

Keywords: bullous pemphigoid; corticosteroid; eosinophil; hematological diseases; mucosal hematoma.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Autoantibodies
  • Autoimmune Diseases*
  • Blister
  • Hemophilia A*
  • Humans
  • Pemphigoid, Bullous*

Substances

  • Autoantibodies

Grants and funding

This work was supported by the National Natural Science Foundation of China [81972945 to LL]; the National Key Research and Development Program of China Grant [2016YEC0901500 to LL]; the Funds of Shunyi District for Health Improvement and Research [Wsjkfzkyzx-2019-y-07 to WZ].